SCHEMBL8773697

SCHEMBL8773697

Oc1cc(-c2ccc(Cl)c(Cl)c2)cc(Cl)c1Cl

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AHR P35869 6/20 0.71
CYP1B1 Q16678 1/20 0.71
HSD17B10 Q99714 3/20 0.48
HPGD P15428 2/20 0.48
TSHR P16473 2/20 0.48
ALDH1A1 P00352 1/20 0.48
ESR2 Q92731 4/20 0.45
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
HSP90AA1 P07900 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX5 P09917 2/20 0.43
ESR1 P03372 3/20 0.43
TTR P02766 1/20 0.42
APP P05067 1/20 0.42
KMO O15229 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10540728 0.84 AHR (0.70) AHRCYP1B1HSD17B10HPGDTSHR
Polychlorinated Biphenyl 126 SCHEMBL6535350 0.84 AHR (1.00) AHRCYP1B1HSD17B10TSHRALDH1A1
Polychlorinated Biphenyl 126 SCHEMBL308662 0.84 AHR (1.00) AHRCYP1B1HSD17B10TSHRALDH1A1
Polychlorinated Biphenyl 126 SCHEMBL6942325 0.84 AHR (1.00) AHRCYP1B1HSD17B10TSHRALDH1A1
SCHEMBL7906570 0.79 AHR (0.70) AHRCYP1B1HSD17B10HPGDTSHR
SCHEMBL8773713 0.79 AHR (0.70) AHRCYP1B1HSD17B10TSHRALDH1A1
SCHEMBL137915 0.78 AHR (1.00) AHRCYP1B1HSD17B10TSHRALDH1A1
SCHEMBL29769221 0.78 AHR (1.00) AHRCYP1B1HSD17B10TSHRALDH1A1
SCHEMBL4456281 0.77 ESR2 (0.65) AHRCYP1B1HSD17B10HPGDTSHR
SCHEMBL5487549 0.77 HSD17B10 (0.67) AHRCYP1B1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0802798-A1 METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS CHIRON CORPORATION (US) 1997-10-29 EP disclosed
WO-1995022992-A1 METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS CHIRON CORPORATION (US) 1995-08-31 WO disclosed